Mednet Logo
HomeNephrology
Nephrology

Nephrology

Clinical discussions on kidney disease management, dialysis, transplantation, and electrolyte disorders.

Recent Discussions

Do you recommend vitamin C supplementation with PO iron in patients with iron deficiency?

2 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

Vitamin C supplementation is unnecessary. Taking the iron with a glass of orange juice away from food and especially coffee optimizes absorption. That being said vitamin C does no harm. See vonSiebenthal et al eClinical Works 2023 (Lancet publication), Benson et al, Lancet Haem 2025 or Auerbach et a...

Would you recommend adding a mineralocorticoid receptor antagonist or endothelin receptor antagonist for a patient with bevacizumab-induced proteinuria who is already on an ACEi or ARB?

1 Answers

Mednet Member
Mednet Member
Nephrology · Yale

Unfortunately, we have no data to guide the choice of anti-proteinuric agents in this particular setting. We do have biological plausibility for antagonizing the endothelin pathway, as we know that vascular endothelial growth factor inhibition results in upregulation of endothelin-1, and the resulta...

How do you decide when to stop routine laboratory monitoring in a patient with CKD Stage 5 who has chosen conservative management?

1 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I normally don't as patients often change their mind when they are sick. However, if the patient requests not to monitor labs then I would honor their wishes.

Do you have a preference between an ACEI and ARB when initiating therapy for a patient with diabetic kidney disease, albuminuria, and hypertension?

1
7 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

Why would you use an ACEi over an ARB these days? Cough is a LOT more common than stated. I see patients all the time who have a ticket, an annoyance that goes away on an ARB. Also, I don't see a $ argument, nor am I aware that ACEi have even been shown to be superior to ARB for reno protection. Als...

What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?

2
1 Answers

Mednet Member
Mednet Member
Nephrology · U Chicago

The biggest difference between osteoporosis and CKD-MBD has to do with the underlying bone mineral laboratories. Generally, with osteoporosis, bone chemistries are relatively normal; there may be a decrease in Vit D. However, with CKD-MBD, there is usually an increase in PTH, potentially abnormaliti...

Do you recommend initiating an ACE inhibitor or ARB in a patient with proteinuric CKD Stage 5?

3 Answers

Mednet Member
Mednet Member
Nephrology · Los Angeles Vascular Access Center

ACE-I’s and ARB’s have been shown to be renal protective, and patients who have stopped these agents do worse than those who continue them. Potassium binders are an excellent option to lower K levels and enable patients to stay on these RAAS inhibitors. I would not take CKD patients off RAAS inhibit...

Would you recommend initiating a SGLT2i for proteinuria secondary to bevacizumab in a patient who has a sub-optimal response to an ACEi or ARB?

2 Answers

Mednet Member
Mednet Member
Nephrology · Yale

We don't have specific data for this scenario, but there is no reason to think that SGLT2i would not have a beneficial role though I agree with Dr. @Dr. First Last that risk/benefit needs to be weighed. At the same time, in this particular scenario, I'd carefully look at the time course of proteinur...

Do you routinely check N-telopeptide levels in patients who you suspect might have immobilization induced hypercalcemia?

1 Answers

Mednet Member
Mednet Member
Nephrology · UCLA

No, I do not check N-telopeptide level in patients with suspected immobilization-induced hypercalcemia. Although N-telopeptide is a sensitive marker of bone resorption, elevated N-telopeptide is not specific to immobilization-induced hypercalcemia and can be elevated in other clinical conditions cha...

In cirrhosis with suspected HRS-AKI and baseline CKD or chronically elevated creatinine, how do you define a clinically meaningful ‘improvement’ during an albumin trial (over 24–48 hours) to distinguish HRS-AKI from volume-responsive AKI?

1 Answers

Mednet Member
Mednet Member
Hepatology · University of Toronto

If the acute rise in serum creatinine returns to the pre-AKI level, the patient has volume-responsive AKI.

Do you temporarily hold diuretics when measuring 24-hour urine calcium levels in the evaluation of primary hyperparathyroidism?

3 Answers

Mednet Member
Mednet Member
Nephrology · University of Chicago Medicine

It is mandatory to stop diuretics at least 2 weeks before evaluating a patient for PHPT. One should have a fasting blood sample on the morning of the end of the collection for calcium phosphate and PTH to complement the urine collection. Thiazide-type diuretics raise serum calcium and lower urine ca...